The Food and Drug Administration (FDA) has approved the COVID-19 vaccine developed by Moderna. It will be the second vaccine following the Pfizer and BioNTech vaccine as the second to be approved in the United States.

Adults from the age of 18 years of age and older in the US will be eligible to take the vaccine. The Moderna vaccine has been found to be 94 percent effective against symptomatic COVID-19 in clinical trials. The vaccine also protects against cases of severe disease. In 30 cases of severe disease among trial participants, and all were in the placebo group.

Also read:
– FDA Authorises Pfizer And BioNTech Vaccine, To Deploy Shortly
– 2020 Winter Solstice: Why December 21st Is Significant
– Apple Puts Taiwanese Supplier Wistron On Probation For Violating Labour Laws

The Pfizer and BioNTech vaccine also indicates promise against severe disease, however, due to insufficient data on its the FDA regards its protection against severe disease as inconclusive.

“With the availability of two vaccines now for the prevention of COVID-19, the FDA has taken another crucial step in the fight against this global pandemic that is causing vast numbers of hospitalizations and deaths in the United States each day,” FDA Commissioner Stephen Hahn said in a press release.

The Moderna like the Pfizer and BioNTech vaccine uses a gene-based technology. It contains a snippet of the genetic material that instructs the body to build copies of that protein in the COVID spike protein. Then it will use those copies to train the immune system to recognise and attack the actual virus.

More than 219,000 people per day on average test positive for the virus in the US. It has also killed more than 314,000 people in the U.S. and nearly 1.7 million worldwide.

For your daily dose of tech, lifestyle, and trending content, make sure to follow Plat4om on Twitter @Plat4omLive, on Instagram @Plat4om, on LinkedIn at Plat4om, and on Facebook at Plat4om. You can also email us at info@plat4om.com and join our channel on Telegram at Plat4om. Finally, don’t forget to subscribe to our YouTube channel HERE.